UBC Faculty Research and Publications

Gap junctions and hemichannels: communicating cell death in neurodevelopment and disease Belousov, Andrei B; Fontes, Joseph D; Freitas-Andrade, Moises; Naus, Christian C Jan 17, 2017

Your browser doesn't seem to have a PDF viewer, please download the PDF to view this item.

Item Metadata

Download

Media
52383-12860_2016_Article_120.pdf [ 330.2kB ]
Metadata
JSON: 52383-1.0362028.json
JSON-LD: 52383-1.0362028-ld.json
RDF/XML (Pretty): 52383-1.0362028-rdf.xml
RDF/JSON: 52383-1.0362028-rdf.json
Turtle: 52383-1.0362028-turtle.txt
N-Triples: 52383-1.0362028-rdf-ntriples.txt
Original Record: 52383-1.0362028-source.json
Full Text
52383-1.0362028-fulltext.txt
Citation
52383-1.0362028.ris

Full Text

REVIEWGap junctions and hemichcommunicating cell deathdsseanwactions mediated by direct cell-cell contact in additioncessing as well as neuronal protection in the brain. Oneprobability of these channels, providing a mean of includingmade of six proteins called connexins [3]. Hemichannelsextracellulara multi-geneals [4].us cell typesg it a very di-ication. WithThe Author(s) BMC Cell Biology 2017, 18(Suppl 1):4DOI 10.1186/s12860-016-0120-xthree (Cx43, Cx30, Cx26), as do oligodendrocytes (Cx32,Mall, Vancouver, BC V6T 1Z3, CanadaFull list of author information is available at the end of the articleregard to the different cell types, neurons express sevendifferent connexins (see below), astrocytes express up to* Correspondence: christian.naus@ubc.ca3Department of Cellular & Physiological Sciences, Faculty of Medicine, LifeSciences Institute, The University of British Columbia, 2350 Health Sciencesjunctions (GJs), clusters of intercellular membrane chan-nels which provide for direct cytoplasmic continuitybetween adjacent cells [1].communicating between intracellular andcompartments. Connexins are encoded byfamily consisting of 20–21 members in mammWithin the mammalian brain, the varioexpress over ten different connexins, makinverse organ regarding intercellular communmechanism mediating such interactions involves gap can also function in their own right, having distinct roles into paracrine signaling (gliotransmission). Furthermore anumber of glial-neuronal interactions exist, and thesehave been implicated in both normal information pro-the channels in the general signaling and physiology of thecells and tissues. A single GJ channel consists of two oppos-ing hemichannels, also known as connexons, which areCx43 play critical roles in neurodevelopment. These connexins also mediate distinct aspects of the CNS response topathological conditions. An imbalance in the expression, translation, trafficking and turnover of connexins, as wellas mutations of connexins, can impact their function in the context of cell death in neurodevelopment and disease.With the ever-increasing understanding of connexins in the brain, therapeutic strategies could be developed totarget these membrane channels in various neurological disorders.BackgroundThe complexity of the mammalian central nervoussystem (CNS) is due in large part to the various celltypes from which it is composed, as well as the differentforms of cellular interactions. These include neuronalinteractions via neurotransmission, as well as glial inter-Gap junctions and connexins in the CNSGJs allow the passive intercellular diffusion of small mole-cules, such as glutamate, glutathione, glucose, adenosinetriphosphate (ATP), cyclic adenosine monophosphate(cAMP), inositol 1,4,5-trisphosphate (IP3), and ions (Ca2+,Na+, K+) [2]. In addition, cells are able to control the opentimepoints when they are expressed in the developing and mature CNS. Both the main neuronal Cx36 and glialneurodevelopment and dAndrei B. Belousov1, Joseph D. Fontes2, Moises Freitas-AnFrom International Gap Junction Conference 2015Valparaiso, Chile. 28 March - 2 April 2015AbstractGap junctions are unique membrane channels that play adeveloping and mature central nervous system (CNS). Theoligomerize into hexamers to form connexons or hemichCNS, with some specificity with regard to the cell types in© The Author(s). 2017 Open Access This articInternational License (http://creativecommonsreproduction in any medium, provided you gthe Creative Commons license, and indicate if(http://creativecommons.org/publicdomain/zeOpen Accessannels:iniseaserade3 and Christian C. Naus3*ignificant role in intercellular communication in thechannels are composed of connexin proteins thatnels. Many different connexins are expressed in thehich distinct connexins are found, as well as thele is distributed under the terms of the Creative Commons Attribution 4.0.org/licenses/by/4.0/), which permits unrestricted use, distribution, andive appropriate credit to the original author(s) and the source, provide a link tochanges were made. The Creative Commons Public Domain Dedication waiverro/1.0/) applies to the data made available in this article, unless otherwise stated.The Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 2 of 11Cx29, Cx47), microglia (Cx43, Cx32, Cx36) and endo-thelial cells (Cx37, Cx40, Cx43) [5–7]. These channelshave distinct functions within the different cell types andtheir expression can change dramatically during neuro-development and injury (see below). GJs in oligodendro-cytes have been shown to be essential for propermyelination [8], as well as potassium buffering [9].Endothelial functions are closely regulated by junctionalinteractions with astrocytes; specifically important arethe connexins expressed in astrocytic endfeet [10, 11]. Inthis context, astrocytes and endothelial cells do not formgap junctions between them, but rather the connexin inastrocytic endfeet may solely function as hemichannels.Cx43 is the most highly expressed connexin in thebrain because it is involved in extensive GJ coupling(GJC) between astrocytes, the most abundant cell typein the brain. GJ communication is also critical for theproliferation and differentiation of neural stem cells [12].Although microglia have been reported to express Cx43and form GJs [13], others have not observed Cx43 im-munoreactivity in microglia [14, 15]; while anothergroup showed that Cx43 does not form GJs in microglia[16], rather it forms hemichannels [17].Connexins are expressed in both neurons and astro-cytes, and are regulated by numerous factors in healthyand pathological conditions. Neuronal GJs and astrocyticGJs are regulated during development and disease. How-ever, given the nature of the tripartite synapse, neuroglialinteractions must also be considered in this context ofsynaptic malfunction.Expression and regulation of neuronal connexins inneural development and adulthoodDuring development, neurons of the rodent CNS ex-press a number of different connexins. These includeCx36 [18–20], Cx30.2 [21], Cx31.1 [22], Cx40 [23], Cx45[24] and Cx50 and Cx57 in the retina [25]. This presum-ably reflects the diversity of neuronal cell types, express-ing a range of connexins, and/or varying functions ofthose connexins in the developing CNS. However,knockout of specifically Cx36 results in near completeloss of neuronal GJC in the mature CNS, indicating thatit is the primary neuronal connexin [26–29]. Cx36 invarious regions of rodent CNS, and Cx35 (the fishorthologue of Cx36) expressed in goldfish Mauthnercells, are often present in mixed chemical and electricalsynapses. Cx36 GJs have been observed in close proximityto α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acidreceptors (AMPARs) [25, 30] as well as N–methyl–D–as-partate (NMDA) receptors (NMDARs) [30–32]. Multiplereports have demonstrated that Cx36 GJs can be tetheredto the cytoskeleton via complex formation with multipleintracellular proteins. Constituents of Cx36-interactingcomplexes include structural proteins, regulators ofchannel activity and gene transcription, as well as factorsinvolved in protein transport, assembly and localization[33–35]. Data suggest that Cx36 may bind these proteinssimultaneously at some GJs within the same neuron andthe binding requires a four amino acid motif (SAYV)present in the C-terminus of the Cx36 protein [34, 35].The interaction of Cx36 with these proteins appears to benecessary for addition into electrical synapses, since theSAYV motif is required for incorporation [36].Cx36 is phosphorylated and its activity is influencedby a number of kinases including cAMP-dependentprotein kinase (PKA), cGMP-dependent protein kinase,protein kinase C (PKC) and casein kinase II [37–39].Ca2+/calmodulin-dependent protein kinase II (CaMKII)interacts with and phosphorylates Cx36 in mouse infer-ior olive neurons and Cx35 in synapses of teleostMauthner cells [40, 41]. The binding of Cx36 to CaMKIImay not be limited to a substrate-enzyme interaction.Rather, there is some indication that the interaction isassociated with changes in expression and/or stability ofthe kinase. It is noteworthy that neurons of Cx36 knock-out mice have reduced CaMKII levels [42].Neuronal GJC is finely regulated among individualplaques (i.e., clusters of GJ channels). A given neuroncan be coupled to a variable number of neighboringneurons and display different degrees of conductancewith each of its coupled partners [32]. Similarly, bindingto CaMKII [40] and the phosphorylation status of Cx36[43] is not uniform within a neuron. Thus, the nature ofsignaling complexes associated with individual GJs pre-sumably facilitates the fine-tuning of individual synapsesand cell-type specific activity [43]. The interactions listedabove have also been reported for non-neuronal connex-ins (e.g., Cx43) suggesting that modulation of GJ activityby these interactions may be a general feature [44].Spatial and temporal variation in GJC during develop-ment of the mammalian CNS has been well documented[45–49]. The expression of Cx36 and associated GJC in-crease during the first two postnatal weeks in most rodentCNS regions (including the cortex and hypothalamus).This initial, relatively robust expression declines duringthe third and fourth postnatal weeks [18, 50, 51]. This isin contrast to other regions of the CNS, such as the spinalcord, where Cx36 expression and coupling is highestduring the late embryonic period followed by a decline inthe first postnatal days [18, 52, 53]. The developmentaldecline in GJC is paired with changes in localization ofCx36 GJs to specific neuronal subtypes in the matureCNS [54, 55]. In the developing CNS in rodents, GJC isobserved between disparate neurons; glutamatergiccells (including pyramidal cells) were found to couplewith interneurons [20, 56] and neurons may couplewith glial cells [57]. However, in the mature CNS, Cx36GJs are found mostly between GABAergic interneuronsThe Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 3 of 11(GABA, γ-aminobutyric acid). It should be noted thatconnexins other than Cx36 also form GJs in the devel-oping CNS [23, 58].Despite the fact that chemical synaptic transmission isabsent while Cx36 expression initiates in development[59], chemical neurotransmitter receptors regulate thedevelopmental expression of neuronal GJC. In the ratand mouse hypothalamus and cortex, Cx36 expression isup-regulated by chronic activation of group II metabo-tropic glutamate receptors (mGluRs) and involvescAMP/PKA-dependent pathways. Conversely, GABAAreceptor activation blocks the developmental increase inCx36 expression [51] and is dependent upon develop-mental depolarization and Ca2+/PKC-dependent signals.The developmental programs of Cx36 expression areexecuted using transcriptional (up-regulation) and trans-lational (down-regulation) regulatory mechanisms [51].These multiple mechanisms contributing to the develop-mental expression of Cx36 and formation of GJC likelyexplain the interregional differences in the developmen-tal timing of GJC. The magnitude of the effects ofneurotransmitter pathways on Cx36 expression suggestsa modulatory rather than a definitive role in develop-mental regulation of neuronal GJC, primarily during theperiod when both electrical and chemical synaptic path-ways are being laid down.Regulation of Cx36 and GJC in the mature CNS occursas well. It allows rapid modification of neuronal connectiv-ity and signaling, including modulation of channel openingprobability and alterations in connexin protein homeosta-sis. Similar to developmental regulation, these regulatorymechanisms are influenced by neurotransmitter signaling.For example, activation of D1 and D2 dopamine receptors,serotonin (5-HT2) receptors, β-adrenoreceptors and eleva-tion of nitric oxide reduces dye coupling between ratcortical neurons within minutes [60]. Similarly, activationof β-adrenoreceptors decreases electrotonic couplingbetween rat hippocampal interneurons [61] and nitricoxide uncouples striatal neurons [62]. Activation of groupII mGluRs in developing mouse cortical neurons induced arapid increase followed by a decrease in Cx36 protein overa 24-h time period; Cx36 mRNA levels were unchangedduring this time, suggesting regulation of protein homeo-stasis [63]. However, whether Cx36 channel opening prob-ability is regulated in developing neurons is not yet known.The activity and regulation of Cx36 and GJC in neuronalinjury and cell deathEvery region of the mature CNS expresses Cx36 and hasGJs, though at levels below that observed during develop-ment [54]. Transient elevation of Cx36 and GJC occursfollowing a wide range of neuronal insults, includingischemia [64–66], spinal cord injury and traumatic braininjury (TBI) [67–69], retinal injury [70], epilepsy [71, 72]and inflammation [73]. The up-regulation of Cx36 andGJs in neurons following injury is very rapid, occurring1–2 h post-injury with a decline in the subsequent 24–48 h [66, 68, 69, 72, 73]. This is in stark contrast to thedevelopmental expression program outlined earlier,which occurs on the timescale of weeks; this differencein timing suggests that disparate regulatory mecha-nisms may be operating in development versus injury.The regulation of GJC expression and activity duringneuronal injury is a potential therapeutic target for redu-cing post-injury neuronal death. Rapid upregulation ofneuronal GJC and Cx36 expression was observed follow-ing multiple types of neuronal injury in adult mice [66]and coincides with the period of massive glutamaterelease from injured cells [74, 75]. The post-injury eleva-tion in coupling and Cx36 was prevented by blockade ofgroup II mGluRs and involves post-transcriptionalmechanisms since no change in Cx36 mRNA levels wereobserved [66]. In contrast to what was observed duringdevelopmental regulation, GABAA receptors were foundto be only indirectly involved in reducing Cx36 expressionafter injury, likely via inhibition of electrical activity. Giventhat neuronal GJC has been shown to be, predominantly,pro-death for neurons following injury (see below),manipulation of pathways that modify expression of Cx36might be a strategy for neuroprotection.The morbidity and mortality of stroke is a direct resultof neuronal death due primarily to ischemic injury andnecrosis [76–79]. Contributing to this is excessive glu-tamate release from ischemic cells producing NMDAR-mediated excitotoxicity and apoptosis [80–82]. Multipletypes of CNS insult beyond stroke, including TBI, epi-lepsy and inflammation, can produce significant neur-onal death, which also involves, in part, NMDARexcitotoxicity [80, 83–86]. While studies have reported arole for GJs in cell death and survival during glutamate-mediated excitotoxicity and neuronal injury, theirpredominant association has been with cell death.A few specific studies have reported a “pro-survival” roleof Cx36 and GJC. For example, pharmacological blockadeof GJs, using non-specific agents, augmented glutamate-induced neuronal death in mouse neuronal corticalcultures [87]. Similarly, secondary neuronal loss in themouse retina, following infrared laser photocoagulationwas most prominent 24–48 h post-injury, was increasedby GJ blockade (using non-selective and relativelyselective blockers for Cx36) and in Cx36 knockoutmice [70]. Both studies support the notion that GJCcontributes to cell survival.The preponderance of reports, however, indicates thatCx36 GJC promotes neuronal death, independent ofinitiating injury. As noted earlier, sustained activation ofgroup II mGluRs increased neuronal GJC and Cx36expression during development; this increase amplifiedThe Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 4 of 11NMDAR-mediated excitotoxicity. Consistent with this,blockade of group II mGluRs prevented increased Cx36 ex-pression and dampened neuronal death from excitotoxicity.These findings support a model where group II mGluRsregulate the developmental program of Cx36 GJC and bydoing so, contribute significantly to death decisions indeveloping neurons [51]. Group II mGluR activation medi-ates injury-associated increases in neuronal GJC. Notsurprisingly, blockade of group II mGluRs reduced injury-mediated neuronal death in multiple injury models [66, 88].Systemic administration of NMDA induced NMDAR-mediated excitotoxicity in the forebrain of adult wild-type mice, which was prevented by co-administration ofthe GJC blocker mefloquine [89]. Similarly, blockade ofGJC by mefloquine significantly reduced ischemic neur-onal death [89] and secondary neuronal death fromcontrolled cortical impact in mice (a model of TBI) [88].Cx36 knockout provided the same reduction in neuronaldeath in both models as pharmacological blockade.Mefloquine did not provide additional survival benefit inCx36 knockouts, suggesting the drug is working primar-ily through inhibition of Cx36 GJs [88, 89]. Additionalstudies also reported a pro-death role for neuronal GJCin NMDAR-mediated excitotoxicity and injury models[90–93]. From this and other work, a model ofglutamate-mediated excitotoxicity centered on neuronalGJs as the primary determinant of magnitude of thesecondary neuronal death following injury has been pro-posed [94, 95]. Despite the difficulty of making broadgeneralizations about the role of GJC in cell death,particularly in non-neuronal tissues [96, 97], blockade ofGJC as a strategy to limit neuronal death following stroke,TBI or other insult remains very attractive.Mechanisms by which neuronal Cx36 and GJC contributeto neuronal death and survivalUnderstanding how neuronal GJs contribute to celldeath and survival is critical, if manipulation of GJC isused as an approach to reduce neuronal damage anddeath in a variety of neurological diseases. Although,some of the studies discussed below were conductedwith the use of non-neuronal cells, they provided animportant information, which potentially may be applic-able to neurons too.Based upon numerous observations of passage of chem-ical substances via GJ channels, it has been proposed thatthe contributions of GJs to cell death and survival are bypropagation between the coupled cells of, respectively,“pro-death” and “pro-survival” GJ-permeable signals[98–100]. Though the identity of these signals remains ob-scure, signaling molecules such as IP3 and reactive oxygenand nitrogen species have been proposed as “pro-death”signals [100–102]. Conversely, molecules such as those in-volved in energy homeostasis (glucose and ATP), and freeradical scavengers (ascorbic acid and reduced glutathione)may be GJ-permeable “pro-survival” signals [96, 103]. Re-cently, a study was conducted in cultured neurons ob-tained from Cx36 knockout mice, in which the neuronswere transduced with lentiviral vectors expressing one ofthree wild-type connexins, including neuronal Cx36 andnon-neuronal Cx43 and Cx31 [93]. Ischemia and NMDARexcitotoxicity were used to induce neuronal death in thosecultures. The study showed that each of the three wild-type connexins induced functional (channel-permeable)GJs and supported neuronal death. The data suggestedthat the role of neuronal GJs in cell death is connexintype-independent and presumably relies on channelactivities of GJ complexes among neurons [93].Another model for the role of GJC in cell death postu-lates that connexins are not involved in cell death mech-anisms via their channel activities, but through direct orindirect regulation of transcriptional programs andapoptotic pathways [96, 104]. This model is based uponthe following observations (however, mostly obtained fornon-neuronal connexins). In osteocytes, Cx43 proteinserves as part of a trans-membrane signal transductionpathway that alters the activity of pro-apoptotic Bcl-2protein, Bad [105]. In non-neuronal cancer cells, Cx26and Cx43 are co-localized with Bcl-2 proteins (Bak, Bcl-xL and Bax) and participate in cell death pathways viadirect interaction with these pro-apoptotic factors[106, 107]. Overexpression of Cx43 in U251 glioblast-oma cells does not increase GJC, but is pro-apoptotic[108]. During ischemia in cardiomyocytes, Cx43 servesas part of a multiprotein complex in mitochondrialmembranes and controls homeostasis of mitochondria[109, 110]. Interference with expression of variousconnexins changes the expression of subsets of apop-totic factors (multiple studies reviewed in [96]) thatpresumably occurs through direct transcriptional con-trol via the “connexin response elements” in pro-apoptotic genes [111] or via direct interaction ofconnexins with transcriptional regulators (e.g., β-catenin) [112]. In addition, a connexin-dependent induc-tion of apoptosis can be connexin- and cell-specific asapoptosis in umbilical vein endothelial cells is induced byoverexpression of Cx37 (but not Cx40 or Cx43), however,overexpression of Cx37 in rat NRK kidney epithelial cellsis not pro-apoptotic [113]. A recent study in neuronal cul-tures utilized a lentiviral transduction of four mutant con-nexins (including various Cx36 and Cx43 mutants), eachof which induced dysfunctional (channel-impermeable)GJs [93]. None of those mutant connexins supportedneuronal death caused by ischemia or NMDAR excito-toxicity. This supported the notion that Cx36 unlikelyplays a role in neuronal death via channel-independentmechanisms, but likley plays a role via channel-dependent mechanisms. It remains to be exploredThe Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 5 of 11whether or not other neuronal connexins (e.g., Cx45)may contribute to neuronal death through the channel-independent mode of action.Finally, the role of connexin hemichannels in cell deathand survival has been proposed. Specifically, for the ner-vous system, the contribution of glial hemichannels viarelease of various channel-permeable “pro-death” agentshas been discussed [96, 103, 114, 115]. These agents pre-sumably include glutamate, ATP, reactive oxygen and ni-trogen species. The existence and role of neuronalhemichannels in neuronal death also has been suggestedbased on experiments with the use of various neuronalinjury models [11, 116]. However, other studies did notsupport the role of neuronal hemichannels in neuronaldeath following ischemia and NMDAR-mediated excito-toxicity [91, 93]. Moreover, the role of Cx36 hemichannelsin neuroprotection via release of ATP has been suggested[117], adding an additional layer of complexity on thecontribution of hemichannels in particular, and connexinsin general, to neuronal death and survival.Expression and regulation of astroglial connexinsIn the CNS, astrocytes are highly coupled to each otherby GJs and play a significant role in the metabolic andtrophic support of neurons [118]. These GJs are com-posed primarily of the channel protein Cx43, and to alesser extent Cx30 [119] and Cx26 [120]. GJs form afunctional syncytium of coupled astrocytes, contributingto spatial buffering, in dealing with elevated concentra-tions of extracellular potassium ions (K+) during in-creased neuronal activity; GJs assist in dispersal of K+accumulated by astrocytes [121].A major advance in understanding astrocytic GJs andconnexins was made through transgenic and knockoutmice (reviewed in [122]). The role of astrocytic GJs hasbeen demonstrated in mouse hippocampal slices, withCx43/Cx30 double knockout mice showing impairedextracellular K+ buffering compared to wild-type mouseslices [123]. It has also been shown that Cx43 plays arole in transient intracellular K+ buffering by mitochon-dria [124]. Pannasch et al. [10] reported key changes inastrocytic and neuronal properties in the absence ofCx43 and Cx30, revealing a major role for astrocyticnetworks in glutamate clearance, K+ buffering, andvolume regulation of the extracellular space during syn-aptic activity. Failure to efficiently clear K+ and glutam-ate results in prolonged neuronal AMPA and NMDAcurrents, as well as astroglial membrane depolarization.Further clarification of the role of Cx30 was obtained byexamining the hippocampus of single Cx30 knockoutmice, demonstrating that Cx30 modulates astrocyteglutamate transport, thereby controlling hippocampalexcitatory synaptic transmission [125]. In this case it wasshown that Cx30 controls astrocytic processes at thesynaptic cleft by modulating their morphology. Glutamateclearance by astrocytes was altered due to thesemorphological changes.In addition to forming GJs, Cx43 also forms hemi-channels, with single connexons communicating directlywith the extracellular space [126]. Hemichannelspredominantly exist in a closed state under normalphysiological conditions, due to ambient levels of Ca2+[127]. However, various cell stresses, such as hypoxia/reoxygenation and metabolic stress, have been reportedto cause opening of hemichannels in cultured astrocytes[128]. Hemichannels enhance neuronal injury underischemic and proinflammatory conditions [129, 130].Regulation of Cx43 in neural developmentDue to the high level of GJC observed during neurodeve-lopment, particularly in the cortex [131, 132], it is not sur-prising that connexins have been shown to be involved.While neurons predominantly express Cx36 postnatally inthe rat and mouse (see above), at prenatal stages neuralprogenitor cells (NPCs), including radial glia, are highlycoupled and express Cx43 and Cx26 [47, 133–136]. Differ-ent approaches to determine the role of these connexinshave been reported, including knockout of Cx43[133, 137, 138] and knockdown of Cx43 and Cx26[134]. While there are some variations in the pheno-types obtained, attributed in part to strain differences[138], the role of Cx43 appears to be due to adhesivefunctions [134], and the C-terminal region is criticalfor NPC migration [133, 136]. Cx26 knockdown wasalso shown to impede NPC migration in the developingrat cortex [134]. Cx26 has been demonstrated to be asubstrate for focal adhesion kinase (FAK), or to functionin stabilizing cell contacts, possibly through interactionswith ZO-1 [139]. The authors suggest that FAK could actas scaffold protein, a function also suggested for Cx43.Since Cx30 is not expressed until 15 days after birth in themouse [119] it is not considered in this context.The activity and regulation of Cx43 and GJC in neuronalinjury and cell deathThe level of GJC between astrocytes, as well as hemichan-nel activity [140], have been shown to be regulated by anumber of factors, including neurotransmitters and neu-romodulators [141–145], extracellular ion concentrations[146] and various pharmacological agents [147–150].Astrocytic GJC and Cx43 expression are altered in variousbrain pathologies, including ischemia [151], stroke [152,153], brain tumours [154], multiple sclerosis [155], brainabscess [156], Alzheimer’s disease [14, 157], and epilepsy[158, 159].In addition, microglial response to brain injury and dis-ease leads to the release of proinflammatory cytokines, in-cluding IL-1β and TNF-α, which impair astrocytic GJC,The Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 6 of 11but enhance hemichannel activity [160]; this leads toincreased neuronal injury. Short application of NMDA in-duces delayed neuronal injury due to excessive release ofglutamate after removal of NMDA [161]. However, neuronsin contact with astrocytes are protected against such glu-tamate toxicity [162, 163]. This neuronal protection was at-tributed to glutamate uptake by astrocytes [164], and as GJsare permeable to glutamate [165], GJC in astrocytes couldimprove glutamate uptake contributing to its dissipation,and thus to neuronal protection. In addition, GJC enablesthe intercellular trafficking of glucose and its metabolitesthrough the astroglial network from blood vessels to distalneurons in an activity-dependent manner [166]. This path-way could sustain neuronal survival in pathological situa-tions that alter energy production, such as hypoglycemia oranoxia/ischemia.Consideration of pannexinsA three-member family of cell membrane channels, thepannexin(s) (Panx 1, 2 and 3), should also be consideredin the context of GJ channels and hemichannels in theCNS. Panxs were discovered due to their homology tothe invertebrate GJ proteins, innexins [167, 168]. Panx1and Panx2 are present in the CNS [169] and have beenlinked to different CNS injury models [170–172]. Be-cause of the ubiquitous expression of Panx1 [168], it hasbeen the most widely investigated member of the Panxfamily [172, 173], however, a recent study reported thatPanx2 expression is not only limited to the CNS [174].Like the connexins, the Panxs traverse the cell mem-brane, but these large pore\channels allow the passage oflarge signaling molecules (e.g., ATP; glucose andglutamate) only between intra- and extracellular com-partments of neurons and possibly astrocytes [175–177],but not between adjoining cells. The evidence for Panxchannels not forming intercellular GJ channels, butrather the equivalent of a connexin hemichannel, hasbeen recently addressed [178] and is attributed to thesteric hindrance provided by the extracellularly glycosyl-ated arginine residue, which interferes with the couplingof two opposing Panx channels [179, 180]. Similarly toconnexins, the Panx C-terminal domain, particularlyfrom Panx1, has been shown to interact with a host ofintracellular factors under specific physiological andpathophysiological conditions [181–183].Because Panx1 forms channels in the plasma membrane,it likely participates in non-synaptic forms of communica-tion to regulate synaptic function under normal conditions,in addition to astrocytic Ca2+ wave propagation and regula-tion of vascular tone [184–186]. Unlike the protective ef-fects of Cx43, however, Panx1 activation under pathologicalconditions is detrimental, contributing to ischemia-inducedexcitotoxicity and ATP-dependent cell death [176, 187–191]. Under ischemic conditions, as seen with oxygen-glucose deprivation in cortical and hippocampal slices,Panx1 channels are irreversibly activated (opened) to pro-mote a progressive and uncontrollable depolarization ofneurons, sustained increments in extracellular concentra-tions of glutamate and aspartate, and subsequent activationof downstream apoptotic and necrotic pathways [192].Others have shown similar association between Panx1 ac-tivity and neuronal death, in different types of neurons[190, 193]. This suggests that Panx1-dependent cell deathmay be a common mechanism in injured neurons.In addition to the anoxic depolarization mechanismassociated with Panx1, it has also been implicated incontributing to inflammation [188, 194]. For example,cells undergoing apoptosis release chemotactic inflam-matory factors to promote phagocytic removal of deadcells. ATP and UTP represent important signaling mole-cules throughout the inflammatory cascade, also thoughtof as danger signals that are released from damaged andnecrotic cells, at least during the initial stages of ische-mia [195], but also more importantly through the Panxand connexin hemichannels. Several studies have re-ported that Panx1-mediated ATP and UTP release is in-duced by caspase activity (caspase 3 and 7) in apoptoticcells [176, 187, 189]. Two potential caspase cleavagesites were identified in the C-terminal of Panx1 [189].The C-terminal cleavage-site-B of Panx1 is evolutionarilyconserved among Panx1 homologues, indicating thatcaspase-dependent cleavage of Panx1 and ATP releasemay be a conserved mechanism in apoptosis [189].Caspase-mediated C-terminal cleavage of Panx1 results inirreversible channel opening, inducing higher if not un-controllable extracellular release of ATP. Findings fromseveral different organ systems collectively suggest thatthis irreversible activation of Panx1 leads to a cascade ofmaladaptive immunity, to include sustained cytokine re-lease, improper resolution of inflammation, impaired im-mune cell chemotaxis, and ultimately cell death [196].Panx1 activity has also been associated in triggering acti-vation of the inflammasome complex [188], however, thisassociation is not fully elucidated and maybe cell-type spe-cific [176, 188]. Of relevance here, in an in vivo experi-mental model of retinal ischemic injury in male mice,genetic ablation of Panx1 suppresses interleukin produc-tion and protects retinal neurons from injury, highlightingthe link between Panx1 and inflammation [193].Interestingly, the reported predominance of caspaseactivation after ischemic injury in female mice [197]raises the intriguing possibility that the endogenousrequirements for Panx1 to regulate neuronal responsesto ischemic injury are different between the two sexes.With respect to connexins, whether Panx membranechannels affect connexin activity, under physiological orpathological conditions, is unknown and potentially afruitful avenue for investigation.The Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 7 of 11Abbreviations5-HT2: Subfamily of serotonin receptors; AMPAR: α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; ATP: Adenosine triphosphate;CaMKII: Ca2+/calmodulin-dependent protein kinase II; cAMP: Cyclic adenosinemonophosphate; CNS: central nervous system; FAK: Focal adhesion kinase;GABA: γ-aminobutyric acid; GJ: Gap junction; GJC: Gap junction coupling;IP3: Inositol 1,4,5-trisphosphate; mGluR: Metabotropic glutamate receptor;NMDAR: N–methyl–D–aspartate receptor; NPC: Neural progenitor cell;Panx: Pannexin; PKA: Protein kinase A; PKC: Protein kinase C; UTP: UridinetriphosphateAcknowledgementsThis work was supported by NIH (R21 NS076925) and the University ofKansas Medical Center funds to A.B.B., in part by KUMC funds to J.D.F., andby a grant from the Canadian Institutes of Health to C.C.N. M.F.A. was fundedby a Heart & Stroke Foundation of Canada Fellowship. C.C.N. holds a CanadaResearch Chair in Gap Junctions and Neurological Disorders.DeclarationsThis article has been published as part of BMC Cell Biology Volume 18Supplement 1, 2017: Proceedings of the International Gap JunctionTherapeutic avenuesAs discussed above, multiple studies have indicated thatblockade of GJs and hemichannels provides neuroprotec-tion in various models of neuronal injury. This suggests apossibility for using the GJ/hemichannel blockade as anovel therapeutic approach. Conceptually, blocking thepropagation between the neurons of GJ-permeable toxicsignals or blocking the release of toxic agents via hemichan-nels would create a “firebreak”, reducing the extent of celldeath. This would prevent excessive neuronal death follow-ing ischemic stroke, TBI and epilepsy, significantly reducingmorbidity and mortality. Because clinical trials for NMDARantagonists as neuroprotective agents largely failed [198],development of new neuroprotective agents based on ma-nipulation of neuronal and astroglial GJs and hemichannelsshould prove to be a valuable alternative approach.ConclusionHowever, as also discussed in the present review, a numberof reports suggest that blockade of GJs and hemichannelsincreases cell death. Clearly, the data on whether GJs arepro-death or pro-survival are conflicting and a convincing,evidence-supported explanation of this phenomenon isabsent. This provides the significant barrier for translatingthe above-described findings to clinical practice. Withoutresolution of conflicting studies, manipulation of GJC inthe clinic, as a novel approach to reduce neuronal death,cannot be advocated. This represents loss of a potentiallyextraordinary benefit to people suffering a range of braininsults. Identifying the underlying mechanisms and deter-mining conditions for the clinical use of GJ blockers thatwill not compromise their strong neuroprotective effectsshould be the major focus of future studies.Conference 2015: second issue. The full contents of the supplement areavailable online at http://bmccellbiol.biomedcentral.com/articles/supplements/volume-18-supplement-1.FundingFunding for publication of this article was obtained from University of KansasMedical Center (KUMC to JDF).Authors’ contributionsAll authors read and approved the final manuscript.Competing interestsThe authors declare that they have no competing interests.Ethics approval and consent to participateThere are no requirements for ethics and consent.Author details1Department of Molecular & Integrative Physiology, University of KansasMedical Center, The University of Kansas, Kansas City, KS 66160, USA.2Department of Biochemistry and Molecular Biology, University of KansasMedical Center, The University of Kansas, Kansas City, KS 66160, USA.3Department of Cellular & Physiological Sciences, Faculty of Medicine, LifeSciences Institute, The University of British Columbia, 2350 Health SciencesMall, Vancouver, BC V6T 1Z3, Canada.Published: 17 January 2017References1. Simon AM, Goodenough DA. Diverse functions of vertebrate gap junctions.Trends Cell Biol. 1998;8(12):477–83.2. Alexander DB, Goldberg GS. Transfer of biologically important moleculesbetween cells through gap junction channels. Curr Med Chem. 2003;10(19):2045–58.3. Sohl G, Willecke K. Gap junctions and the connexin protein family.Cardiovasc Res. 2004;62(2):228–32.4. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M,Deutsch U, Sohl G. Structural and functional diversity of connexin genes inthe mouse and human genome. Biol Chem. 2002;383(5):725–37.5. De Bock M, Wang N, Decrock E, Bol M, Gadicherla AK, Culot M, Cecchelli R,Bultynck G, Leybaert L. Endothelial calcium dynamics, connexin channelsand blood–brain barrier function. Prog Neurobiol. 2013;108:1–20.6. De Bock M, Culot M, Wang N, Bol M, Decrock E, De Vuyst E, da Costa A,Dauwe I, Vinken M, Simon AM, et al. Connexin channels provide a target tomanipulate brain endothelial calcium dynamics and blood–brain barrierpermeability. J Cereb Blood Flow Metab. 2011;31(9):1942–57.7. Ransom B, Giaume C. Gap junctions and hemichannels. In: Kettenmann H,Ransom B, editors. Neuroglia. New York: Oxford University Press; 2012.8. Menichella DM, Goodenough DA, Sirkowski E, Scherer SS, Paul DL. Connexins arecritical for normal myelination in the CNS. J Neurosci. 2003;23(13):5963–73.9. Menichella DM, Majdan M, Awatramani R, Goodenough DA, Sirkowski E,Scherer SS, Paul DL. Genetic and physiological evidence thatoligodendrocyte gap junctions contribute to spatial buffering of potassiumreleased during neuronal activity. J Neurosci. 2006;26(43):10984–91.10. Pannasch U, Vargova L, Reingruber J, Ezan P, Holcman D, Giaume C, Sykova E,Rouach N. Astroglial networks scale synaptic activity and plasticity. Proc Natl AcadSci U S A. 2011;108(20):8467–72.11. Froger N, Orellana JA, Calvo CF, Amigou E, Kozoriz MG, Naus CC, Saez JC,Giaume C. Inhibition of cytokine-induced connexin43 hemichannel activityin astrocytes is neuroprotective. Mol Cell Neurosci. 2010;45(1):37–46.12. Worsdorfer P, Maxeiner S, Markopoulos C, Kirfel G, Wulf V, Auth T, Urschel S,von Maltzahn J, Willecke K. Connexin expression and functional analysis ofgap junctional communication in mouse embryonic stem cells. Stem Cells.2008;26(2):431–9.13. Eugenin EA, Eckardt D, Theis M, Willecke K, Bennett MV, Saez JC. Microgliaat brain stab wounds express connexin 43 and in vitro form functional gapjunctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc Natl Acad Sci U S A. 2001;98(7):4190–5.14. Mei X, Ezan P, Giaume C, Koulakoff A. Astroglial connexin immunoreactivityis specifically altered at beta-amyloid plaques in beta-amyloid precursorprotein/presenilin1 mice. Neuroscience. 2010;171(1):92–105.15. Theodoric N, Bechberger JF, Naus CC, Sin WC. Role of gap junction proteinconnexin43 in astrogliosis induced by brain injury. PLoS One.2012;7(10):e47311.The Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 8 of 1116. Wasseff SK, Scherer SS. Activated microglia do not form functional gapjunctions in vivo. J Neuroimmunol. 2014;269(1–2):90–3.17. Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, Sonobe Y,Mizuno T, Suzumura A. Tumor necrosis factor-alpha induces neurotoxicityvia glutamate release from hemichannels of activated microglia in anautocrine manner. J Biol Chem. 2006;281(30):21362–8.18. Belluardo N, Mudo G, Trovato-Salinaro A, Le Gurun S, Charollais A,Serre-Beinier V, Amato G, Haefliger JA, Meda P, Condorelli DF.Expression of connexin36 in the adult and developing rat brain. BrainRes. 2000;865(1):121–38.19. Rash JE, Kamasawa N, Davidson KG, Yasumura T, Pereda AE, Nagy JI.Connexin composition in apposed gap junction hemiplaques revealed bymatched double-replica freeze-fracture replica immunogold labeling. JMembr Biol. 2012;245(5–6):333–44.20. Venance L, Rozov A, Blatow M, Burnashev N, Feldmeyer D, Monyer H.Connexin expression in electrically coupled postnatal rat brain neurons.Proc Natl Acad Sci U S A. 2000;97(18):10260–5.21. Kreuzberg MM, Deuchars J, Weiss E, Schober A, Sonntag S, Wellershaus K,Draguhn A, Willecke K. Expression of connexin30.2 in interneurons of thecentral nervous system in the mouse. Mol Cell Neurosci. 2008;37(1):119–34.22. Dere E, Zheng-Fischhofer Q, Viggiano D, Gironi Carnevale UA, Ruocco LA,Zlomuzica A, Schnichels M, Willecke K, Huston JP, Sadile AG. Connexin31.1deficiency in the mouse impairs object memory and modulates open-fieldexploration, acetylcholine esterase levels in the striatum, and cAMPresponse element-binding protein levels in the striatum and piriform cortex.Neuroscience. 2008;153(2):396–405.23. Personius KE, Chang Q, Mentis GZ, O’Donovan MJ, Balice-Gordon RJ. Reducedgap junctional coupling leads to uncorrelated motor neuron firing andprecocious neuromuscular synapse elimination. Proc Natl Acad Sci U S A. 2007;104(28):11808–13.24. Li X, Kamasawa N, Ciolofan C, Olson CO, Lu S, Davidson KG, Yasumura T,Shigemoto R, Rash JE, Nagy JI. Connexin45-containing neuronal gap junctions inrodent retina also contain connexin36 in both apposing hemiplaques, formingbihomotypic gap junctions, with scaffolding contributed by zonula occludens-1. JNeurosci. 2008;28(39):9769–89.25. Puller C, de Sevilla Muller LP, Janssen-Bienhold U, Haverkamp S. ZO-1 and thespatial organization of gap junctions and glutamate receptors in the outerplexiform layer of the mammalian retina. J Neurosci. 2009;29(19):6266–75.26. De Zeeuw CI, Chorev E, Devor A, Manor Y, Van Der Giessen RS, De Jeu MT,Hoogenraad CC, Bijman J, Ruigrok TJ, French P, et al. Deformation ofnetwork connectivity in the inferior olive of connexin 36-deficient mice iscompensated by morphological and electrophysiological changes at thesingle neuron level. J Neurosci. 2003;23(11):4700–11.27. Deans MR, Gibson JR, Sellitto C, Connors BW, Paul DL. Synchronous activityof inhibitory networks in neocortex requires electrical synapses containingconnexin36. Neuron. 2001;31(3):477–85.28. Hormuzdi SG, Pais I, LeBeau FE, Towers SK, Rozov A, Buhl EH, Whittington MA,Monyer H. Impaired electrical signaling disrupts gamma frequency oscillations inconnexin 36-deficient mice. Neuron. 2001;31(3):487–95.29. Long MA, Deans MR, Paul DL, Connors BW. Rhythmicity without synchrony inthe electrically uncoupled inferior olive. J Neurosci. 2002;22(24):10898–905.30. Hamzei-Sichani F, Davidson KG, Yasumura T, Janssen WG, Wearne SL, HofPR, Traub RD, Gutierrez R, Ottersen OP, Rash JE. Mixed electrical-chemicalsynapses in adult rat hippocampus are primarily glutamatergic and coupledby connexin-36. Front Neuroanat. 2012;6:13.31. Nagy JI. Evidence for connexin36 localization at hippocampal mossy fiberterminals suggesting mixed chemical/electrical transmission by granulecells. Brain Res. 2012;1487:107–22.32. Hoge GJ, Davidson KG, Yasumura T, Castillo PE, Rash JE, Pereda AE. Theextent and strength of electrical coupling between inferior olivary neuronsis heterogeneous. J Neurophysiol. 2011;105(3):1089–101.33. Ciolofan C, Li XB, Olson C, Kamasawa N, Gebhardt BR, Yasumura T, Morita M,Rash JE, Nagy JI. Association of connexin36 and zonula occludens-1 withzonula occludens-2 and the transcription factor zonula occludens-1-associated nucleic acid-binding protein at neuronal gap junctions in rodentretina. Neuroscience. 2006;140(2):433–51.34. Li X, Lu S, Nagy JI. Direct association of connexin36 with zonula occludens-2and zonula occludens-3. Neurochem Int. 2009;54(5–6):393–402.35. Li X, Lynn BD, Nagy JI. The effector and scaffolding proteins AF6 andMUPP1 interact with connexin36 and localize at gap junctions that formelectrical synapses in rodent brain. Eur J Neurosci. 2012;35(2):166–81.36. Helbig I, Sammler E, Eliava M, Bolshakov AP, Rozov A, Bruzzone R, Monyer H,Hormuzdi SG. In vivo evidence for the involvement of the carboxy terminaldomain in assembling connexin 36 at the electrical synapse. Mol CellNeurosci. 2010;45(1):47–58.37. Kothmann WW, Li X, Burr GS, O’Brien J. Connexin 35/36 is phosphorylatedat regulatory sites in the retina. Vis Neurosci. 2007;24(3):363–75.38. Patel LS, Mitchell CK, Dubinsky WP, O’Brien J. Regulation of gap junctioncoupling through the neuronal connexin Cx35 by nitric oxide and cGMP.Cell Commun Adhes. 2006;13(1–2):41–54.39. Urschel S, Hoher T, Schubert T, Alev C, Sohl G, Worsdorfer P, Asahara T,Dermietzel R, Weiler R, Willecke K. Protein kinase A-mediated phosphorylation ofconnexin36 in mouse retina results in decreased gap junctional communicationbetween AII amacrine cells. J Biol Chem. 2006;281(44):33163–71.40. Flores CE, Cachope R, Nannapaneni S, Ene S, Nairn AC, Pereda AE. Variabilityof distribution of Ca(2+)/calmodulin-dependent kinase II at mixed synapseson the mauthner cell: colocalization and association with connexin 35. JNeurosci. 2010;30(28):9488–99.41. Alev C, Urschel S, Sonntag S, Zoidl G, Fort AG, Hoher T, Matsubara M,Willecke K, Spray DC, Dermietzel R. The neuronal connexin36 interacts withand is phosphorylated by CaMKII in a way similar to CaMKII interaction withglutamate receptors. Proc Natl Acad Sci U S A. 2008;105(52):20964–9.42. Zlomuzica A, Viggiano D, Degen J, Binder S, Ruocco LA, Sadile AG, Willecke K,Huston JP, Dere E. Behavioral alterations and changes in Ca/calmodulin kinaseII levels in the striatum of connexin36 deficient mice. Behav Brain Res. 2012;226(1):293–300.43. Kothmann WW, Massey SC, O’Brien J. Dopamine-stimulateddephosphorylation of connexin 36 mediates AII amacrine cell uncoupling.J Neurosci. 2009;29(47):14903–11.44. Herve JC, Derangeon M, Sarrouilhe D, Giepmans BN, Bourmeyster N. Gapjunctional channels are parts of multiprotein complexes. Biochim BiophysActa. 2012;1818(8):1844–65.45. Eugenin EA, Basilio D, Saez JC, Orellana JA, Raine CS, Bukauskas F, Bennett MV,Berman JW. The role of gap junction channels during physiologic andpathologic conditions of the human central nervous system. J NeuroimmunePharmacol. 2012;7(3):499–518.46. Dermietzel R, Traub O, Hwang TK, Beyer E, Bennett MV, Spray DC, Willecke K.Differential expression of three gap junction proteins in developing andmature brain tissues. Proc Natl Acad Sci U S A. 1989;86:10148–52.47. Cina C, Bechberger JF, Ozog MA, Naus CC. Expression of connexins in embryonicmouse neocortical development. J Comp Neurol. 2007;504(3):298–313.48. Belliveau DJ, Kidder GM, Naus CCG. Expression of gap junction genesduring postnatal neural development. Dev Genet. 1991;12:308–17.49. Belliveau DJ, Naus CCG. Differential localization of gap junction mRNAs indeveloping rat brain. Dev Neurosci. 1995;17:81–96.50. Arumugam H, Liu X, Colombo PJ, Corriveau RA, Belousov AB. NMDAreceptors regulate developmental gap junction uncoupling via CREBsignaling. Nat Neurosci. 2005;8(12):1720–6.51. Park W-M, Wang Y, Park S, Denisova JV, Fontes JD, Belousov AB. Interplay ofchemical neurotransmitters regulates developmental increase in electricalsynapses. J Neurosci. 2011;31(16):5909–20.52. Mentis GZ, Diaz E, Moran LB, Navarrete R. Increased incidence of gapjunctional coupling between spinal motoneurones following transientblockade of NMDA receptors in neonatal rats. J Physiol. 2002;544(Pt 3):757–64.53. Pastor AM, Mentis GZ, De La Cruz RR, Diaz E, Navarrete R. Increasedelectrotonic coupling in spinal motoneurons after transient botulinumneurotoxin paralysis in the neonatal rat. J Neurophysiol. 2003;89(2):793–805.54. Connors BW. Chapter 6: Electrical signaling with neuronal gap junctions. In:Harris A, Locke D, editors. Connexins: A Guide. New York: Humana Press;2009. pp. 143–64.55. Hestrin S, Galarreta M. Electrical synapses define networks of neocorticalGABAergic neurons. Trends Neurosci. 2005;28(6):304–9.56. Meyer AH, Katona I, Blatow M, Rozov A, Monyer H. In vivo labeling ofparvalbumin-positive interneurons and analysis of electrical coupling inidentified neurons. J Neurosci. 2002;22(16):7055–64.57. Alvarez-Maubecin V, Garcia-Hernandez F, Williams JT, Van Bockstaele EJ.Functional coupling between neurons and glia. J Neurosci. 2000;20(11):4091–8.58. Yu YC, He S, Chen S, Fu Y, Brown KN, Yao XH, Ma J, Gao KP, Sosinsky GE,Huang K, et al. Preferential electrical coupling regulates neocortical lineage-dependent microcircuit assembly. Nature. 2012;486(7401):113–7.The Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 9 of 1159. Ben-Ari Y. Developing networks play a similar melody. Trends Neurosci.2001;24(6):353–60.60. Roerig B, Feller MB. Neurotransmitters and gap junctions in developingneural circuits. Brain Res Brain Res Rev. 2000;32(1):86–114.61. Zsiros V, Maccaferri G. Noradrenergic modulation of electrical coupling inGABAergic networks of the hippocampus. J Neurosci. 2008;28(8):1804–15.62. O’Donnell P, Grace AA. Cortical afferents modulate striatal gap junctionpermeability via nitric oxide. Neuroscience. 1997;76(1):1–5.63. Song J-H, Wang Y, Fontes JD, Belousov AB. Regulation of connexin 36expression during development. Neurosci Lett. 2012;513(1):17–9.64. de Pina-Benabou MH, Szostak V, Kyrozis A, Rempe D, Uziel D, Urban-Maldonado M, Benabou S, Spray DC, Federoff HJ, Stanton PK, et al. Blockadeof gap junctions in vivo provides neuroprotection after perinatal globalischemia. Stroke. 2005;36(10):2232–7.65. Oguro K, Jover T, Tanaka H, Lin Y, Kojima T, Oguro N, Grooms SY, BennettMV, Zukin RS. Global ischemia-induced increases in the gap junctionalproteins connexin 32 (Cx32) and Cx36 in hippocampus and enhancedvulnerability of Cx32 knock-out mice. J Neurosci. 2001;21(19):7534–42.66. Wang Y, Song J-H, Denisova JV, Park W-M, Fontes JD, Belousov AB.Neuronal gap junction coupling is regulated by glutamate and plays criticalrole in cell death during neuronal injury. J Neurosci. 2012;32(2):713–25.67. Chang Q, Pereda A, Pinter MJ, Balice-Gordon RJ. Nerve injury induces gapjunctional coupling among axotomized adult motor neurons. J Neurosci.2000;20(2):674–84.68. Frantseva MV, Kokarovtseva L, Naus CG, Carlen PL, MacFabe D, PerezVelazquez JL. Specific gap junctions enhance the neuronal vulnerability tobrain traumatic injury. J Neurosci. 2002;22(3):644–53.69. Ohsumi A, Nawashiro H, Otani N, Ooigawa H, Toyooka T, Yano A, NomuraN, Shima K. Alteration of gap junction proteins (connexins) following lateralfluid percussion injury in rats. Acta Neurochir Suppl. 2006;96:148–50.70. Striedinger K, Petrasch-Parwez E, Zoidl G, Napirei M, Meier C, Eysel UT,Dermietzel R. Loss of connexin36 increases retinal cell vulnerability tosecondary cell loss. Eur J Neurosci. 2005;22(3):605–16.71. Gajda Z, Gyengesi E, Hermesz E, Ali KS, Szente M. Involvement of gapjunctions in the manifestation and control of the duration of seizures in ratsin vivo. Epilepsia. 2003;44(12):1596–600.72. Perez Velazquez JL, Valiante TA, Carlen PL. Modulation of gap junctionalmechanisms during calcium-free induced field burst activity: a possible rolefor electrotonic coupling in epileptogenesis. J Neurosci. 1994;14(7):4308–17.73. Garrett FG, Durham PL. Differential expression of connexins in trigeminalganglion neurons and satellite glial cells in response to chronic or acutejoint inflammation. Neuron Glia Biol. 2008;4(4):295–306.74. Guyot LL, Diaz FG, O’Regan MH, McLeod S, Park H, Phillis JW. Real-timemeasurement of glutamate release from the ischemic penumbra of the ratcerebral cortex using a focal middle cerebral artery occlusion model.Neurosci Lett. 2001;299(1–2):37–40.75. Stoffel M, Plesnila N, Eriskat J, Furst M, Baethmann A. Release of excitatoryamino acids in the penumbra of a focal cortical necrosis. J Neurotrauma.2002;19(4):467–77.76. Fortuna S, Pestalozza S, Lorenzini P, Bisso GM, Morelli L, Michalek H.Transient global brain hypoxia-ischemia in adult rats: neuronal damage, glialproliferation, and alterations in inositol phospholipid hydrolysis. NeurochemInt. 1997;31(4):563–9.77. Kirino T, Tamura A, Sano K. Delayed neuronal death in the rat hippocampusfollowing transient forebrain ischemia. Acta Neuropathol. 1984;64(2):139–47.78. Petito CK, Feldmann E, Pulsinelli WA, Plum F. Delayed hippocampal damagein humans following cardiorespiratory arrest. Neurology. 1987;37(8):1281–6.79. Xu BN, Yabuki A, Mishina H, Miyazaki M, Maeda M, Ishii S. Pathophysiologyof brain swelling after acute experimental brain compression anddecompression. Neurosurgery. 1993;32(2):289–96.80. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependentneurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci.2004;61(6):657–68.81. Reyes M, Reyes A, Opitz T, Kapin MA, Stanton PK. Eliprodil, a non-competitive, NR2B-selective NMDA antagonist, protects pyramidal neuronsin hippocampal slices from hypoxic/ischemic damage. Brain Res. 1998;782(1–2):212–8.82. Lees KR. Cerestat and other NMDA antagonists in ischemic stroke.Neurology. 1997;49(5 Suppl 4):S66–9.83. Biegon A, Fry PA, Paden CM, Alexandrovich A, Tsenter J, Shohami E.Dynamic changes in N-methyl-D-aspartate receptors after closed headinjury in mice: Implications for treatment of neurological and cognitivedeficits. Proc Natl Acad Sci U S A. 2004;101(14):5117–22.84. Giza CC, Maria NS, Hovda DA. N-methyl-D-aspartate receptor subunitchanges after traumatic injury to the developing brain. J Neurotrauma.2006;23(6):950–61.85. Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids andNMDA receptors in traumatic brain injury. Science. 1989;244(4906):798–800.86. Rogawski MA. The NMDA receptor, NMDA antagonists and epilepsytherapy. A status report. Drugs. 1992;44(3):279–92.87. Ozog MA, Siushansian R, Naus CC. Blocked gap junctional couplingincreases glutamate-induced neurotoxicity in neuron-astrocyte co-cultures.J Neuropathol Exp Neurol. 2002;61(2):132–41.88. Belousov AB, Wang Y, Song J-H, Denisova JV, Berman NE, Fontes JD.Neuronal gap junctions play a role in the secondary neuronal deathfollowing controlled cortical impact. Neurosci Lett. 2012;524(1):16–9.89. Wang Y, Denisova JV, Kang KS, Fontes JD, Zhu BT, Belousov AB. Neuronalgap junctions are required for NMDA receptor-mediated excitotoxicity:implications in ischemic stroke. J Neurophysiol. 2010;104(6):3551–6.90. Cusato K, Bosco A, Rozental R, Guimaraes CA, Reese BE, Linden R, Spray DC.Gap junctions mediate bystander cell death in developing retina. JNeurosci. 2003;23(16):6413–22.91. de Rivero Vaccari JC, Corriveau RA, Belousov AB. Gap junctions are requiredfor NMDA receptor-dependent cell death in developing neurons. JNeurophysiol. 2007;98(5):2878–86.92. Frantseva MV, Kokarovtseva L, Perez Velazquez JL. Ischemia-induced braindamage depends on specific gap-junctional coupling. J Cereb Blood FlowMetab. 2002;22(4):453–62.93. Fontes JD, Ramsey J, Polk JM, Koop A, Denisova JV, Belousov AB. Death ofneurons following injury requires conductive neuronal gap junctionchannels but not a specific connexin. PLoS One. 2015;10(5), e0125395.94. Belousov AB, Fontes JD. Neuronal gap junctions: making and breakingconnections during development and injury. Trends Neurosci. 2013;36(4):227–36.95. Belousov AB, Fontes JD. Neuronal gap junction coupling as the primarydeterminant of the extent of glutamate-mediated excitotoxicity. J NeuralTransm. 2014;121(8):837–46.96. Decrock E, Vinken M, De Vuyst E, Krysko DV, D’Herde K, Vanhaecke T,Vandenabeele P, Rogiers V, Leybaert L. Connexin-related signaling in celldeath: to live or let die? Cell Death Differ. 2009;16(4):524–36.97. Perez Velazquez JL, Frantseva MV, Naus CC. Gap junctions and neuronalinjury: protectants or executioners? Neuroscientist. 2003;9(1):5–9.98. Udawatte C, Ripps H. The spread of apoptosis through gap-junctionalchannels in BHK cells transfected with Cx32. Apoptosis. 2005;10(5):1019–29.99. Cusato K, Ripps H, Zakevicius J, Spray DC. Gap junctions remain openduring cytochrome c-induced cell death: relationship of conductance to‘bystander’ cell killing. Cell Death Differ. 2006;13(10):1707–14.100. Decrock E, De Bock M, Wang N, Gadicherla AK, Bol M, Delvaeye T,Vandenabeele P, Vinken M, Bultynck G, Krysko DV, et al. IP3, a small moleculewith a powerful message. Biochim Biophys Acta. 2013;1833(7):1772–86.101. Decrock E, Krysko DV, Vinken M, Kaczmarek A, Crispino G, Bol M, Wang N,De Bock M, De Vuyst E, Naus CC, et al. Transfer of IP3 through gap junctionsis critical, but not sufficient, for the spread of apoptosis. Cell Death Differ.2012;19(6):947–57.102. Monaco G, Decrock E, Akl H, Ponsaerts R, Vervliet T, Luyten T, De Maeyer M,Missiaen L, Distelhorst CW, De Smedt H, et al. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain ofBcl-2 versus Bcl-Xl. Cell Death Differ. 2012;19(2):295–309.103. Decrock E, Vinken M, Bol M, D’Herde K, Rogiers V, Vandenabeele P, KryskoDV, Bultynck G, Leybaert L. Calcium and connexin-based intercellularcommunication, a deadly catch? Cell Calcium. 2011;50(3):310–21.104. Vinken M, Decrock E, Leybaert L, Bultynck G, Himpens B, Vanhaecke T,Rogiers V. Non-channel functions of connexins in cell growth and celldeath. Biochim Biophys Acta. 2012;1818(8):2002–8.105. Plotkin LI, Manolagas SC, Bellido T. Transduction of cell survival signals byconnexin-43 hemichannels. J Biol Chem. 2002;277(10):8648–57.106. Kanczuga-Koda L, Sulkowski S, Koda M, Skrzydlewska E, Sulkowska M.Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectalcancer. World J Gastroenterol. 2005;11(10):1544–8.107. Kanczuga-Koda L, Sulkowski S, Tomaszewski J, Koda M, Sulkowska M,Przystupa W, Golaszewska J, Baltaziak M. Connexins 26 and 43 correlatewith Bak, but not with Bcl-2 protein in breast cancer. Oncol Rep. 2005;14(2):325–9.The Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 10 of 11108. Huang RP, Hossain MZ, Huang R, Gano J, Fan Y, Boynton AL. Connexin 43(cx43) enhances chemotherapy-induced apoptosis in human glioblastomacells. Int J Cancer. 2001;92(1):130–8.109. Ruiz-Meana M, Rodriguez-Sinovas A, Cabestrero A, Boengler K, Heusch G,Garcia-Dorado D. Mitochondrial connexin43 as a new player in thepathophysiology of myocardial ischaemia-reperfusion injury. Cardiovasc Res.2008;77(2):325–33.110. Goubaeva F, Mikami M, Giardina S, Ding B, Abe J, Yang J. Cardiacmitochondrial connexin 43 regulates apoptosis. Biochem Biophys ResCommun. 2007;352(1):97–103.111. Stains JP, Lecanda F, Screen J, Towler DA, Civitelli R. Gap junctionalcommunication modulates gene transcription by altering the recruitment ofSp1 and Sp3 to connexin-response elements in osteoblast promoters. J BiolChem. 2003;278(27):24377–87.112. Ai Z, Fischer A, Spray DC, Brown AM, Fishman GI. Wnt-1 regulation ofconnexin43 in cardiac myocytes. J Clin Invest. 2000;105(2):161–71.113. Seul KH, Kang KY, Lee KS, Kim SH, Beyer EC. Adenoviral delivery of humanconnexin37 induces endothelial cell death through apoptosis. BiochemBiophys Res Commun. 2004;319(4):1144–51.114. Saez JC, Schalper KA, Retamal MA, Orellana JA, Shoji KF, Bennett MV. Cellmembrane permeabilization via connexin hemichannels in living and dyingcells. Exp Cell Res. 2010;316(15):2377–89.115. Davidson JO, Green CR, LF BN, O’Carroll SJ, Fraser M, Bennet L, Jan Gunn A.Connexin hemichannel blockade improves outcomes in a model of fetalischemia. Ann Neurol. 2012;71(1):121–32.116. Orellana JA, Shoji KF, Abudara V, Ezan P, Amigou E, Saez PJ, Jiang JX, NausCC, Saez JC, Giaume C. Amyloid beta-induced death in neurons involvesglial and neuronal hemichannels. J Neurosci. 2011;31(13):4962–77.117. Schock SC, Leblanc D, Hakim AM, Thompson CS. ATP release by way ofconnexin 36 hemichannels mediates ischemic tolerance in vitro. BiochemBiophys Res Commun. 2008;368(1):138–44.118. Jensen AM, Chiu S, Murphy S. Astrocyte Networks. In: Astrocytes:Pharmacology and Function. New York: Academic; 1993. p. 309–29.119. Nagy JI, Patel D, Ochalski PA, Stelmack GL. Connexin30 in rodent, cat andhuman brain: selective expression in gray matter astrocytes, co-localizationwith connexin43 at gap junctions and late developmental appearance.Neuroscience. 1999;88(2):447–68.120. Nagy JI, Li X, Rempel J, Stelmack G, Patel D, Staines WA, Yasumura T, Rash JE.Connexin26 in adult rodent central nervous system: demonstration atastrocytic gap junctions and colocalization with connexin30 and connexin43. JComp Neurol. 2001;441(4):302–23.121. Walz W, Hertz L. Functional interactions between neurons and astrocytes. II.Potassium homeostasis at the cellular level. Prog Neurobiol. 1983;20:133–83.122. Giaume C, Theis M. Pharmacological and genetic approaches to studyconnexin-mediated channels in glial cells of the central nervous system.Brain Res Rev. 2010;63(1–2):160–76.123. Wallraff A, Kohling R, Heinemann U, Theis M, Willecke K, Steinhauser C. Theimpact of astrocytic gap junctional coupling on potassium buffering in thehippocampus. J Neurosci. 2006;26(20):5438–47.124. Kozoriz MG, Church J, Ozog MA, Naus CC, Krebs C. Temporary sequestration ofpotassium by mitochondria in astrocytes. J Biol Chem. 2010;285(41):31107–19.125. Pannasch U, Freche D, Dallerac G, Ghezali G, Escartin C, Ezan P, Cohen-Salmon M, Benchenane K, Abudara V, Dufour A, et al. Connexin 30 setssynaptic strength by controlling astroglial synapse invasion. Nat Neurosci.2014;17(4):549–58.126. Goodenough DA, Paul DL. Beyond the gap: functions of unpairedconnexon channels. Nat Rev Mol Cell Biol. 2003;4(4):285–94.127. Li HY, Liu TF, Lazrak A, Peracchia C, Goldberg GS, Lampe PD, Johnson R.Properties and regulation of gap junctional hemichannels in the plasmamembranes of cultured cells. J Cell Biol. 1996;134(4):1019–30.128. Le HT, Sin WC, Lozinsky S, Bechberger J, Vega JL, Guo XQ, Saez JC, Naus CC.Gap junction intercellular communication mediated by connexin43 inastrocytes is essential for their resistance to oxidative stress. J Biol Chem.2014;289(3):1345–54.129. Contreras JE, Sanchez HA, Veliz LP, Bukauskas FF, Bennett MV, Saez JC.Role of connexin-based gap junction channels and hemichannels inischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev.2004;47(1–3):290–303.130. Orellana JA, von Bernhardi R, Giaume C, Saez JC. Glial hemichannels andtheir involvement in aging and neurodegenerative diseases. Rev Neurosci.2012;23(2):163–77.131. Yuste R, Peinado A, Katz LC. Neuronal domains in developing neocortex.Science. 1992;257:665–9.132. Peinado A, Yuste R, Katz LC. Extensive dye coupling between rat neocorticalneurons during the period of circuit formation. Neuron. 1993;10:103–14.133. Cina C, Maass K, Theis M, Willecke K, Bechberger JF, Naus CC. Involvementof the cytoplasmic C-terminal domain of connexin43 in neuronal migration.J Neurosci. 2009;29(7):2009–21.134. Elias LA, Wang DD, Kriegstein AR. Gap junction adhesion is necessary forradial migration in the neocortex. Nature. 2007;448(7156):901–7.135. Elias LAB, Kriegstein AR. Gap junctions: Multifaceted regulators of embryoniccortical development. Trends Neurosci. 2010;31(5):243–50.136. Elias LAB, Turmaine M, Parnavelas JG, Kriegstein AR. Connexin43 mediatesthe tangential to radial migratory switch in ventrally derived corticalinterneurons. J Neurosci. 2010;30(20):7072–7.137. Fushiki S, Perez Velazquez JL, Zhang L, Bechberger JF, Carlen PL, Naus CC.Changes in neuronal migration in neocortex of connexin43 null mutantmice. J Neuropathol Exp Neurol. 2003;62(3):304–14.138. Wiencken-Barger AE, Djukic B, Casper KB, McCarthy KD. A role forConnexin43 during neurodevelopment. GLIA. 2007;55(7):675–86.139. Valiente M, Ciceri G, Rico B, Marin O. Focal adhesion kinase modulates radialglia-dependent neuronal migration through connexin-26. J Neurosci. 2011;31(32):11678–91.140. Giaume C, Leybaert L, Naus CC, Saez JC. Connexin and pannexinhemichannels in brain glial cells: properties, pharmacology, and roles. FrontPharmacol. 2013;4:88.141. Ochalski PAY, Sawchuk MA, Hertzberg EL, Nagy JI. Astrocytic gap junctionremoval, connexin43 redistribution, and epitope masking at excitatoryamino acid lesion sites in rat brain. GLIA. 1995;14(4):279–94.142. Vukelic JI, Yamamoto T, Hertzberg EL, Nagy JI. Depletion of connexin43-immunoreactivity in astrocytes after kainic acid-induced lesions in rat brain.NeurosciLett. 1991;130:120–4.143. Giaume C, Cordier J, Glowinski J. Endothelins inhibit junctional permeabilityin cultured mouse astrocytes. Euro J Neurosci. 1992;4:877–81.144. Giaume C, Briley M, Marien M. Noradrenergic control of gap junctionpermeability in cultured striatal astrocytes. In: Noradrenergic Mechanisms inParkinson’s Disease. Boca Raton: CRC Press; 1994. p. 205–24.145. Giaume C, Marin P, Cordier J, Glowinski J, Premont J. Adrenergic regulationof intercellular communications between cultured striatal astrocytes fromthe mouse. Proc Natl Acad Sci U S A. 1991;88:5577–81.146. Enkvist MO, McCarthy KD. Astroglial gap junction communication isincreased by treatment with either glutamate or high K+ concentration. JNeurochem. 1994;62(2):489–95.147. Konietzko U, Muller CM. Astrocytic dye coupling in rat hippocampus:Topography, developmental onset, and modulation by protein kinase C.Hippocampus. 1994;4:297–306.148. MacVicar BA, Jahnsen H. Uncoupling of CA3 pyramidal neurons bypropionate. Brain Res. 1985;330:141–5.149. Mantz J, Cordier J, Giaume C. Effects of general anesthetics on intercellularcommunications mediated by gap junctions between astrocytes in primaryculture. Anesthesiology. 1993;78:892–901.150. Anders JJ. Lactic acid inhibition of gap junctional intercellularcommunication in in vitro astrocytes as measured by fluorescence recoveryafter laser photobleaching. GLIA. 1988;1:371–9.151. Hossain MZ, Peeling J, Sutherland GR, Hertzberg EL, Nagy JI. Ischemia-induced cellular redistribution of the astrocytic gap junctional proteinconnexin43 in rat brain. Brain Res. 1994;652:311–22.152. Nakase T, Yoshida Y, Nagata K. Enhanced connexin 43 immunoreactivity inpenumbral areas in the human brain following ischemia. Glia. 2006;54(5):369–75.153. Haupt C, Witte OW, Frahm C. Temporal profile of connexin 43 expression afterphotothrombotic lesion in rat brain. Neuroscience. 2007;144(2):562–70.154. Kolar K, Freitas-Andrade M, Bechberger JF, Krishnan H, Goldberg GS, NausCC, Sin WC. Podoplanin: a marker for reactive gliosis in gliomas and braininjury. J Neuropathol Exp Neurol. 2015;74(1):64–74.155. Brand-Schieber E, Werner P, Iacobas DA, Iacobas S, Beelitz M, Lowery SL,Spray DC, Scemes E. Connexin43, the major gap junction protein ofastrocytes, is down-regulated in inflamed white matter in an animal modelof multiple sclerosis. J Neurosci Res. 2005;80(6):798–808.156. Karpuk N, Burkovetskaya M, Fritz T, Angle A, Kielian T.Neuroinflammation leads to region-dependent alterations in astrocytegap junction communication and hemichannel activity. J Neurosci.2011;31(2):414–25.activation opens pannexin channels via Src family kinases. J Neurosci. 2012;32(36):12579–88.183. Bhalla-Gehi R, Penuela S, Churko JM, Shao Q, Laird DW. Pannexin1 andpannexin3 delivery, cell surface dynamics, and cytoskeletal interactions. JBiol Chem. 2010;285(12):9147–60.184. Billaud M, Sandilos JK, Isakson BE. Pannexin 1 in the regulation of vasculartone. Trends Cardiovasc Med. 2012;22(3):68–72.185. Thompson RJ, Macvicar BA. Connexin and pannexin hemichannels ofneurons and astrocytes. Channels (Austin). 2008;2(2):81–6.186. Zoidl G, Petrasch-Parwez E, Ray A, Meier C, Bunse S, Habbes HW, Dahl G,Dermietzel R. Localization of the pannexin1 protein at postsynaptic sites inthe cerebral cortex and hippocampus. Neuroscience. 2007;146(1):9–16.187. Sandilos JK, Chiu YH, Chekeni FB, Armstrong AJ, Walk SF, Ravichandran KS,Bayliss DA. Pannexin 1, an ATP release channel, is activated by caspasecleavage of its pore-associated C-terminal autoinhibitory region. J BiolChem. 2012;287(14):11303–11.The Author(s) BMC Cell Biology 2017, 18(Suppl 1):4 Page 11 of 11157. Koulakoff A, Mei X, Orellana JA, Saez JC, Giaume C. Glial connexinexpression and function in the context of Alzheimer’s disease. BiochimBiophys Acta. 2012;1818(8):2048–57.158. Naus CC, Bechberger JF, Paul DL. Gap junction gene expression in humanseizure disorder. Exp Neurol. 1991;111(2):198–203.159. Elisevich K, Rempel SA, Smith BJ, Edvardsen K. Hippocampal connexin 43expression in human complex partial seizure disorder. Exp Neurol. 1997;145(1):154–64.160. Retamal MA, Schalper KA, Shoji KF, Orellana JA, Bennett MV, Saez JC.Possible involvement of different connexin43 domains in plasmamembrane permeabilization induced by ischemia-reperfusion. J Membr Biol.2007;218(1–3):49–63.161. Hartley DM, Choi DW. Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture. J Pharmacol Exp Ther. 1989;250(2):752–8.162. Mattson MP, Rychlik B. Glia protect hippocampal neurons against excitatoryamino acid-induced degeneration: involvement of fibroblast growth factor.Int J Dev Neurosci. 1990;8(4):399–415.163. Rosenberg PA, Aizenman E. Hundred-fold increase in neuronal vulnerabilityto glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex[published erratum appears in Neurosci Lett 1990 Aug 24;116(3): 399].Neurosci Lett. 1989;103(2):162–8.164. Rosenberg PA. Accumulation of extracellular glutamate and neuronal death inastrocyte-poor cortical cultures exposed to glutamine. GLIA. 1991;4(1):91–100.165. Goldberg GS, Lampe PD, Nicholson BJ. Selective transfer of endogenousmetabolites through gap junctions composed of different connexins. NatCell Biol. 1999;1(7):457–9.166. Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C. Astroglialmetabolic networks sustain hippocampal synaptic transmission. Science.2008;322(5907):1551–5.167. Panchin YV. Evolution of gap junction proteins–the pannexin alternative. JExp Biol. 2005;208(Pt 8):1415–9.168. Baranova A, Ivanov D, Petrash N, Pestova A, Skoblov M, Kelmanson I, ShaginD, Nazarenko S, Geraymovych E, Litvin O, et al. The mammalian pannexinfamily is homologous to the invertebrate innexin gap junction proteins.Genomics. 2004;83(4):706–16.169. Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H. Pannexins, a familyof gap junction proteins expressed in brain. Proc Natl Acad Sci U S A. 2003;100(23):13644–9.170. Thompson RJ, Zhou N, MacVicar BA. Ischemia opens neuronal gap junctionhemichannels. Science. 2006;312(5775):924–7.171. Bargiotas P, Krenz A, Hormuzdi SG, Ridder DA, Herb A, Barakat W,Penuela S, von Engelhardt J, Monyer H, Schwaninger M. Pannexins inischemia-induced neurodegeneration. Proc Natl Acad Sci U S A. 2011;108(51):20772–7.172. MacVicar BA, Thompson RJ. Non-junction functions of pannexin-1 channels.Trends Neurosci. 2010;33(2):93–102.173. Dahl G, Keane RW. Pannexin: from discovery to bedside in 11+/−4 years?Brain Res. 2012;1487:150–9.174. Le Vasseur M, Lelowski J, Bechberger JF, Sin WC, Naus CC. Pannexin 2protein expression is not restricted to the CNS. Front Cell Neurosci.2014;8:392.175. Bruzzone R, Barbe MT, Jakob NJ, Monyer H. Pharmacological properties ofhomomeric and heteromeric pannexin hemichannels expressed in Xenopusoocytes. J Neurochem. 2005;92(5):1033–43.176. Qu Y, Misaghi S, Newton K, Gilmour LL, Louie S, Cupp JE, Dubyak GR,Hackos D, Dixit VM. Pannexin-1 is required for ATP release during apoptosisbut not for inflammasome activation. J Immunol. 2011;186(11):6553–61.177. Bao L, Locovei S, Dahl G. Pannexin membrane channels aremechanosensitive conduits for ATP. FEBS Lett. 2004;572(1–3):65–8.178. Sosinsky GE, Boassa D, Dermietzel R, Duffy HS, Laird DW, MacVicar B, Naus CC,Penuela S, Scemes E, Spray DC, et al. Pannexin channels are not gap junctionhemichannels. Channels (Austin). 2011;5(3):193–7.179. Penuela S, Bhalla R, Gong XQ, Cowan KN, Celetti SJ, Cowan BJ, Bai D, ShaoQ, Laird DW. Pannexin 1 and pannexin 3 are glycoproteins that exhibitmany distinct characteristics from the connexin family of gap junctionproteins. J Cell Sci. 2007;120(Pt 21):3772–83.180. Boassa D, Qiu F, Dahl G, Sosinsky G. Trafficking dynamics of glycosylatedpannexin 1 proteins. Cell Commun Adhes. 2008;15(1):119–32.181. Sandilos JK, Bayliss DA. Physiological mechanisms for the modulation ofpannexin 1 channel activity. J Physiol. 2012;590(Pt 24):6257–66.188. Silverman WR, de Rivero Vaccari JP, Locovei S, Qiu F, Carlsson SK, Scemes E,Keane RW, Dahl G. The pannexin 1 channel activates the inflammasome inneurons and astrocytes. J Biol Chem. 2009;284(27):18143–51.189. Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER,Armstrong AJ, Penuela S, Laird DW, Salvesen GS, et al. Pannexin 1 channelsmediate ‘find-me’ signal release and membrane permeability duringapoptosis. Nature. 2010;467(7317):863–7.190. Gulbransen BD, Bashashati M, Hirota SA, Gui X, Roberts JA, MacDonald JA,Muruve DA, McKay DM, Beck PL, Mawe GM, et al. Activation of neuronalP2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis.Nat Med. 2012;18(4):600–4.191. Orellana JA, Froger N, Ezan P, Jiang JX, Bennett MV, Naus CC, Giaume C,Saez JC. ATP and glutamate released via astroglial connexin 43hemichannels mediate neuronal death through activation of pannexin 1hemichannels. J Neurochem. 2011;118(5):826–40.192. Shestopalov VI, Slepak VZ. Molecular pathways of pannexin1-mediatedneurotoxicity. Front Physiol. 2014;5:23.193. Dvoriantchikova G, Ivanov D, Barakat D, Grinberg A, Wen R, Slepak VZ,Shestopalov VI. Genetic ablation of Pannexin1 protects retinal neurons fromischemic injury. PLoS One. 2012;7(2):e31991.194. Murphy N, Cowley TR, Richardson JC, Virley D, Upton N, Walter D, LynchMA. The neuroprotective effect of a specific P2X(7) receptor antagonistderives from its ability to inhibit assembly of the NLRP3 inflammasome inglial cells. Brain Pathol. 2012;22(3):295–306.195. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D,Woodson RI, Ostankovich M, Sharma P, et al. Nucleotides released byapoptotic cells act as a find-me signal to promote phagocytic clearance.Nature. 2009;461(7261):282–6.196. Adamson SE, Leitinger N. The role of pannexin1 in the induction andresolution of inflammation. FEBS Lett. 2014;588(8):1416–22.197. Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD. Sex differences in caspaseactivation after stroke. Stroke. 2009;40(5):1842–8.198. Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinicaltrials for stroke and traumatic brain injury? Lancet Neurol. 2002;1(6):383–6.182. Weilinger NL, Tang PL, Thompson RJ. Anoxia-induced NMDA receptor

Cite

Citation Scheme:

        

Citations by CSL (citeproc-js)

Usage Statistics

Share

Embed

Customize your widget with the following options, then copy and paste the code below into the HTML of your page to embed this item in your website.
                        
                            <div id="ubcOpenCollectionsWidgetDisplay">
                            <script id="ubcOpenCollectionsWidget"
                            src="{[{embed.src}]}"
                            data-item="{[{embed.item}]}"
                            data-collection="{[{embed.collection}]}"
                            data-metadata="{[{embed.showMetadata}]}"
                            data-width="{[{embed.width}]}"
                            async >
                            </script>
                            </div>
                        
                    
IIIF logo Our image viewer uses the IIIF 2.0 standard. To load this item in other compatible viewers, use this url:
http://iiif.library.ubc.ca/presentation/dsp.52383.1-0362028/manifest

Comment

Related Items